KLRC1 and cancer: In contrast to Bexte et al. but similar to our previous publications [24,29], in this study, no significant improvement was observed in the killing of AML and B-ALL cells by NKG2A-KO-expanded NK cells, showing that NK cells might have different levels of cytotoxicity against different cancer cells.